IRB
Differentiating “Public” and “Private” Internet Spaces in IRB Review
The difference between “public” and “private” internet spaces has gained importance with the growing research use of internet and social media platforms as data sources. Read more:
Coronavirus disease 2019 in children
Ran D. Goldman, MD FRCPC, contributed to the article Coronavirus disease 2019 in children in the journal Canadian Family Physician.
Engagement in Research for Pragmatic Clinical Trials
Judith Carrithers contributed to the article Engagement in Research for Pragmatic Clinical Trials for the NIH Health Care Systems Research Collaboratory.
Q&A Part 1 – Evaluating Payment to Participate in Research: Ethical and Regulatory Issues
Dr. Gelinas answers audience questions we weren’t able to address during the webinar.
Protocol Feasibility to Promote Trial Efficiency
Many studies do not accrue subjects at the site level, which contributes to a significant amount of waste of staff time and monetary resources. Read more:
Study Activation: A Complex Process That Doesn’t Have to Be Painful
If the clinical development time of a new treatment is to ever decrease, reducing the time in study activation is necessary so actual research can be done.
How Research Informs the COVID-19 Response
Research doesn’t just inform medical treatment; it informs public health and public policy, and it helps explain human behaviors. Read more:
Large Hospital System Requires Central IRB Partner
From ad hoc IRB support to sIRB partnerships and fully managed IRB office services, Advarra has institutions and hospital systems covered. No matter how unique the situation, Advarra partners with ...
Ask Advarra Live: The Real-World Impact of COVID-19 on Research
The unprecedented COVID-19 pandemic has quickly changed how we live and work. This extraordinary situation has resulted in a significant impact on IRB-approved protocols and research yet to go through ...
Economic vulnerability and payment for research participation
Luke Gelinas co-authored the article "Economic vulnerability and payment for research participation" in Clinical Trials
IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider
Advarra IRB experts discuss unique issues that research involving emerging infectious diseases like coronavirus can raise for IRB review. Read more:
Are “Virtual Trials” Mainstream Yet?
Advarra VP of Insitutional Services James Riddle discusses using virtual trial components in traditional study designs. Read more:
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.